$264 Million is the total value of JNBA Financial Advisors's 545 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | New | ALLERGAN PLC | $750,000 | – | 2,472 | +100.0% | 0.28% | – |
| DES | New | WISDOMTREE TRsmallcap divid | $49,000 | – | 697 | +100.0% | 0.02% | – |
| FTAI | New | FORTRESS TRANS INFRST INVS L | $29,000 | – | 1,605 | +100.0% | 0.01% | – |
| VFC | New | V F CORP | $27,000 | – | 388 | +100.0% | 0.01% | – |
| NCQ | New | NOVACOPPER INC | $26,000 | – | 52,200 | +100.0% | 0.01% | – |
| ITC | New | ITC HLDGS CORP | $24,000 | – | 750 | +100.0% | 0.01% | – |
| PFG | New | PRINCIPAL FINL GROUP INC | $21,000 | – | 405 | +100.0% | 0.01% | – |
| MLPN | New | CREDIT SUISSE NASSAU BRHx link cush mlp | $17,000 | – | 590 | +100.0% | 0.01% | – |
| AMLP | New | ALPS ETF TRalerian mlp | $13,000 | – | 810 | +100.0% | 0.01% | – |
| WYND | New | WYNDHAM WORLDWIDE CORP | $8,000 | – | 100 | +100.0% | 0.00% | – |
| ZIOP | New | ZIOPHARM ONCOLOGY INC | $7,000 | – | 550 | +100.0% | 0.00% | – |
| MOO | New | MARKET VECTORS ETF TRagribus etf | $5,000 | – | 85 | +100.0% | 0.00% | – |
| TWTR | New | TWITTER INC | $5,000 | – | 125 | +100.0% | 0.00% | – |
| CSAL | New | COMMUNICATIONS SALES&LEAS IN | $3,000 | – | 110 | +100.0% | 0.00% | – |
| VGK | New | VANGUARD INTL EQUITY INDEX Fftse europe etf | $3,000 | – | 60 | +100.0% | 0.00% | – |
| New | BIOLASE INC | $2,000 | – | 1,096 | +100.0% | 0.00% | – | |
| CAR | New | AVIS BUDGET GROUP | $2,000 | – | 50 | +100.0% | 0.00% | – |
| RTK | New | RENTECH INC | $1,000 | – | 800 | +100.0% | 0.00% | – |
| HRS | New | HARRIS CORP DEL | $0 | – | 3 | +100.0% | 0.00% | – |
| HAWK | New | BLACKHAWK NETWORK HLDGS INC | $0 | – | 3 | +100.0% | 0.00% | – |
| BOTA | New | BIOTA PHARMACEUTIALS INC | $0 | – | 166 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-07-29
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 42 | Q3 2023 | 11.3% |
| VANGUARD SPECIALIZED PORTFOL | 42 | Q3 2023 | 11.0% |
| VANGUARD TOTAL STOCK MARKET ET | 42 | Q3 2023 | 12.6% |
| ISHARES TR | 42 | Q3 2023 | 4.8% |
| VANGUARD MSCI EMERGING MARKETS | 42 | Q3 2023 | 4.6% |
| VANGUARD LARGE-CAP ETF | 42 | Q3 2023 | 4.7% |
| VANGUARD INTL EQUITY INDEX F | 42 | Q3 2023 | 4.1% |
| ISHARES TR | 42 | Q3 2023 | 2.7% |
| ISHARES TR | 42 | Q3 2023 | 1.9% |
| MICROSOFT CORP. | 42 | Q3 2023 | 3.6% |
View JNBA Financial Advisors's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-26 |
| 13F-HR | 2024-02-08 |
| 13F-HR | 2023-11-02 |
| 13F-HR | 2023-08-03 |
| 13F-HR | 2023-05-02 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-07-22 |
| 13F-HR | 2022-04-29 |
| 13F-HR | 2022-02-03 |
View JNBA Financial Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.